Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01872273

Blood Cell Response to Exercise

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
USDA Grand Forks Human Nutrition Research Center · Federal
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Moderate exercise is recommended to improve cardiovascular health in obese and overweight people particularly with metabolic syndrome (MetS) that have hypertension, elevated fasting blood sugar, and elevated blood lipids. This study is being done to determine how platelets respond when a person performs an initial period of moderate exercise.

Conditions

Interventions

TypeNameDescription
OTHERModerate Physical ExerciseThis intervention is comprised of two separate visits at least one week apart. The purpose of visit 1 is to determine the cycle ergometer workload that produces a moderate exercise intensity of 60% heart rate reserve to be used on visit 2. The purpose of visit 2 is to determine changes in platelet reactivity in response to moderate exercise.

Timeline

Start date
2013-02-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2013-06-07
Last updated
2022-02-02

Source: ClinicalTrials.gov record NCT01872273. Inclusion in this directory is not an endorsement.

Blood Cell Response to Exercise (NCT01872273) · Clinical Trials Directory